| Priced On | Company | Symbol | Shares Initial | Shares Revised | Range Initial | Range Revised | Priced | Open |
|---|---|---|---|---|---|---|---|---|
| No IPOs have priced this week | ||||||||
| Priced On | Company | Symbol | Shares Initial | Shares Revised | Range Initial | Range Revised | Priced | Open |
|---|---|---|---|---|---|---|---|---|
| bluebird bio |
BLUE
|
5.0 M | $14.00-16.00 | -18 | ||||
| Lead Underwriter: JP Morgan, BofA Merrill Lynch Co-managers: Cowen, Canaccord Genuity, Wedbush PacGrow Life Sciences Description: Biotech focused on using gene therapy to improve lives of patients with genetic & orphan diseases (NASDAQ) |
||||||||
| PTC Therapeutics |
PTCT
|
6.9 M | $13.00-16.00 | - | ||||
| Lead Underwriter: JP Morgan, Credit Suisse Co-managers: Cowen, Wedbush Description: Biopharmaceutical company developing small-molecule drugs targeting post-transcriptional control processes (NASDAQ) |
||||||||
| Regado Biosciences |
RGDO
|
5.0 M | $14.00-16.00 | - | ||||
| Lead Underwriter: BMO Capital Markets, Cowen Co-managers: Canaccord Genuity, Needham, Wedbush Description: Biopharmaceutical company developing antithrombotic drug systems for cardiovascular indications (NASDAQ) |
||||||||





